NO20070091L - Sukkerbelegg og fremgangsmate for dette - Google Patents

Sukkerbelegg og fremgangsmate for dette

Info

Publication number
NO20070091L
NO20070091L NO20070091A NO20070091A NO20070091L NO 20070091 L NO20070091 L NO 20070091L NO 20070091 A NO20070091 A NO 20070091A NO 20070091 A NO20070091 A NO 20070091A NO 20070091 L NO20070091 L NO 20070091L
Authority
NO
Norway
Prior art keywords
dosage forms
solid dosage
coatings
methods
sugar coating
Prior art date
Application number
NO20070091A
Other languages
English (en)
Inventor
Deborah Marie Sherman
John C Clark
John J Michelucci
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20070091L publication Critical patent/NO20070091L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)

Abstract

Preparater beskrives som er spesielt nyttige som belegg for faste doseringsformer av terapeutiske midler samt faste doseringsformer som omfatter slike belegg, fremgangsmåter for fremstilling av slike faste doseringsformer, og produktene fra disse fremgangsmåter. Belegningspreparatene gir generelt utmerket styrke og resistens overfor oppsprekking, selv når de påføres fieksible/svellbare tablettkjerner så som kjerner av hydrogeltype. Preparatene viser også utmerkede luktblokkerende karakteristikker.
NO20070091A 2004-06-07 2007-01-05 Sukkerbelegg og fremgangsmate for dette NO20070091L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57766804P 2004-06-07 2004-06-07
PCT/US2005/019972 WO2005120466A2 (en) 2004-06-07 2005-06-07 Sugar coatings and methods therefor

Publications (1)

Publication Number Publication Date
NO20070091L true NO20070091L (no) 2007-01-05

Family

ID=35351681

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070091A NO20070091L (no) 2004-06-07 2007-01-05 Sukkerbelegg og fremgangsmate for dette

Country Status (23)

Country Link
US (2) US20050271724A1 (no)
EP (1) EP1753407B1 (no)
JP (1) JP5000509B2 (no)
CN (1) CN101267809A (no)
AR (1) AR049142A1 (no)
AU (1) AU2005251793B2 (no)
BR (1) BRPI0511663A (no)
CA (1) CA2566771A1 (no)
CR (1) CR8778A (no)
EC (1) ECSP067049A (no)
ES (1) ES2623363T3 (no)
GT (1) GT200500141A (no)
IL (1) IL179537A0 (no)
MX (1) MXPA06014229A (no)
NO (1) NO20070091L (no)
NZ (1) NZ551676A (no)
PA (1) PA8636001A1 (no)
PE (1) PE20060245A1 (no)
RU (1) RU2428178C2 (no)
SV (1) SV2006002136A (no)
TW (1) TW200602089A (no)
UA (1) UA86413C2 (no)
WO (1) WO2005120466A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
WO2008013084A1 (fr) * 2006-07-25 2008-01-31 Kowa Company, Ltd. Préparation enrobée de sucre et son procédé de fabrication
AU2007325207A1 (en) * 2006-11-29 2008-06-05 Wyeth Estrogen/ serm and estrogen/ progestin bi-layer tablets
CL2008000095A1 (es) * 2007-01-12 2008-05-16 Wyeth Corp Composicion de tableta en tableta que comprende una tableta central con estrogenos, un rellenador/diluyente, un rellenador/aglomerante, un componente polimerico y una capa de tableta exterior comprimida con agentes terapeuticos, un rellenador/diluyen
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
US20090274757A1 (en) * 2008-05-01 2009-11-05 Wyeth Pharmaceutical polish formulations
WO2009158584A1 (en) * 2008-06-27 2009-12-30 Wyeth Dual adhesive technology
CN101744725B (zh) * 2008-12-09 2013-04-17 北京华素制药股份有限公司 缓释微丸包衣生产工艺参数的优化方法
EP2375903A4 (en) * 2008-12-15 2012-09-19 Somnus Therapeutics Inc METHOD FOR TREATING SILENTNESS
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US20110052687A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Extended release pharmaceutical composition of paliperidone
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8663671B2 (en) * 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
US20110223244A1 (en) * 2010-03-09 2011-09-15 Elan Pharma International Limited Alcohol resistant enteric pharmaceutical compositions
EP2568973A2 (en) 2010-05-11 2013-03-20 Sensient Colors LLC Film coating composition and methods of making and using the same
HRP20151321T1 (hr) * 2011-01-20 2016-01-29 Bionevia Pharmaceuticals Inc. Epalrestat ili njegov derivat u oblicima s prilagođenim otpuštanjem te postupci uporabe istih
US8846089B2 (en) * 2011-06-03 2014-09-30 Wakunaga Pharmaceutical Co., Ltd. Sugar-coated preparation and production method for the same
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
US20170196816A1 (en) * 2014-06-02 2017-07-13 Nipro Corporation Laser-printable tablet, and method for manufacturing the same
EP3240842B1 (en) * 2015-01-01 2023-05-03 Ideal Cures Pvt. Ltd. Novel film coating composition
US20180000742A1 (en) * 2015-01-29 2018-01-04 Novo Nordisk A/S Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
RU2753049C2 (ru) * 2016-08-04 2021-08-11 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи Легкие для глотания покрытия и покрытые ими субстраты
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
MX2019008440A (es) * 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
EP0716597A1 (en) * 1993-08-30 1996-06-19 Warner-Lambert Company Tablet coating based on a melt-spun mixture of a saccharide and apolymer
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
CA2367669A1 (en) * 1999-03-29 2000-10-05 American Home Products Corporation Coating system
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU2003213337A1 (en) * 2002-03-14 2003-09-22 Daiichi Suntory Pharma Co., Ltd. Tablet containing pilsicainide hydrochloride (wet)

Also Published As

Publication number Publication date
GT200500141A (es) 2006-01-10
PE20060245A1 (es) 2006-05-03
ES2623363T3 (es) 2017-07-11
TW200602089A (en) 2006-01-16
PA8636001A1 (es) 2006-05-16
RU2006140093A (ru) 2008-07-20
WO2005120466A3 (en) 2007-04-19
WO2005120466A2 (en) 2005-12-22
AR049142A1 (es) 2006-06-28
UA86413C2 (ru) 2009-04-27
NZ551676A (en) 2010-11-26
ECSP067049A (es) 2007-02-28
SV2006002136A (es) 2006-02-15
CA2566771A1 (en) 2005-12-22
JP2008501803A (ja) 2008-01-24
RU2428178C2 (ru) 2011-09-10
BRPI0511663A (pt) 2008-01-02
US20110136772A1 (en) 2011-06-09
MXPA06014229A (es) 2007-05-04
EP1753407A2 (en) 2007-02-21
JP5000509B2 (ja) 2012-08-15
US20050271724A1 (en) 2005-12-08
IL179537A0 (en) 2007-05-15
AU2005251793A1 (en) 2005-12-22
EP1753407B1 (en) 2017-03-08
CN101267809A (zh) 2008-09-17
AU2005251793B2 (en) 2010-07-15
CR8778A (es) 2007-10-01

Similar Documents

Publication Publication Date Title
NO20070091L (no) Sukkerbelegg og fremgangsmate for dette
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
ZA200701656B (en) Humanized anti-cment antagonists
WO2008016643A3 (en) Certain chemical entities, compositions, and methods
IL244803A0 (en) Human anti-beta7 antibodies and their use
WO2006020773A3 (en) Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
CA2514473A1 (en) Fused bicyclic nitrogen-containing heterocycles
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
WO2007079164A3 (en) Protein kinase inhibitors
WO2005062881A3 (en) Gene therapy using transposon-based vectors
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
WO2005082341A3 (en) NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
MXPA05008397A (es) Composiciones farmaceuticas que comprenden derivados de tieno[2,3-c]piridina y uso de las mismas.
MY162563A (en) Compositions and methods for treating hyperproliferative diseases
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
WO2008016666A3 (en) Certain chemical entities, compositions, and methods
WO2007140263A3 (en) Macrophage migration inhibitory factor antagonists and methods of using same
MX2009004961A (es) Procedimiento de revestimiento de azucar y deflectores para el mismo.
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
WO2008051610A3 (en) Treatment of impulse control disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application